14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $20.69 $23.95 Friday, 3rd May 2024 EXEL stock ended at $21.90. This is 0.99% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.40% from a day low at $21.73 to a day high of $22.47.
90 days $20.02 $24.07
52 weeks $18.52 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
Feb 23, 2023 $17.41 $17.66 $17.37 $17.43 2 064 935
Feb 22, 2023 $17.34 $17.47 $17.21 $17.37 4 056 742
Feb 21, 2023 $17.45 $17.55 $17.39 $17.45 5 684 762
Feb 17, 2023 $17.48 $17.64 $17.35 $17.49 3 229 979
Feb 16, 2023 $17.67 $17.80 $17.47 $17.51 1 890 510
Feb 15, 2023 $18.00 $18.13 $17.59 $17.77 2 551 042
Feb 14, 2023 $17.77 $18.16 $17.65 $18.08 3 635 199
Feb 13, 2023 $17.43 $17.72 $17.13 $17.69 1 812 841
Feb 10, 2023 $17.58 $17.69 $17.43 $17.55 2 724 571
Feb 09, 2023 $17.75 $18.05 $17.43 $17.58 3 065 198
Feb 08, 2023 $17.00 $17.93 $16.99 $17.76 3 424 211
Feb 07, 2023 $17.16 $17.35 $17.00 $17.29 2 537 320
Feb 06, 2023 $17.47 $17.50 $17.27 $17.27 1 574 820
Feb 03, 2023 $17.58 $17.74 $17.48 $17.55 1 880 585
Feb 02, 2023 $17.62 $17.78 $17.41 $17.61 1 973 506
Feb 01, 2023 $17.53 $17.68 $17.09 $17.56 3 301 378
Jan 31, 2023 $17.34 $17.65 $17.34 $17.62 2 537 628
Jan 30, 2023 $17.41 $17.52 $17.34 $17.39 1 944 801
Jan 27, 2023 $17.70 $17.80 $17.47 $17.47 1 597 849
Jan 26, 2023 $17.64 $17.80 $17.46 $17.71 2 081 484
Jan 25, 2023 $17.28 $17.37 $17.00 $17.33 2 384 848
Jan 24, 2023 $17.03 $17.60 $17.00 $17.36 3 673 054
Jan 23, 2023 $16.71 $17.03 $16.56 $17.02 5 460 621
Jan 20, 2023 $16.64 $16.85 $16.36 $16.73 7 944 546
Jan 19, 2023 $16.32 $16.61 $16.31 $16.53 2 951 500
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT